Blank Cover Image

Usefulness of the Outpatient Chemotherapy Regimen of S-1 Followed by Weekly Paclitaxel for Far Advanced Gastric Cancer

フォーマット:
論文(リポジトリ)
責任表示:
FURUKAWA, Koichi ; WATANABE, Kazuhiko ; ABE, Yukihiro ; AIBA, Tuneo ; IKARASHI, Kentarou ; HATA, Koujiro ; Ho, Nichau ; TSUKIOKA, Satosi
出版情報:
Niigata University School of Medicine, 2005-09
掲載情報:
Acta medica et biologica — Acta medica et biologica
ISSN:
05677734  CiNii Research  Webcat Plus  JAIRO
著者名:
FURUKAWA, Koichi
WATANABE, Kazuhiko
ABE, Yukihiro
AIBA, Tuneo
IKARASHI, Kentarou
HATA, Koujiro
Ho, Nichau
TSUKIOKA, Satosi
続きを見る
巻:
53
通号:
3
開始ページ:
73
終了ページ:
77
概要:
To evaluate outpatient treatment, as well as the clinical effect of 1M tegafur-0.4M gimestat-1M otastat potassium(S-1) followed by weekly Paclitaxel(PTX) for patients with far advanced inoperable gastric cancer, we analyzed retrospectively the appropriateness of outpatient anticancer chemotherapy from the standards of overall survival and time without symptom and toxicity(TWiST) as a quality-adjusted survival analysis. A total of 18 patients with advanced inoperable gastric cancer were treated with S-1 as first line single-agent chemotherapy from May 1, 2000 to September 30, 2000 at the Niigata City General Hospital. S-1 (60mg-120mg/m^2/orally twice daily on Days 1-28 followed by a 14 days rest/course) was repeated until progression of the disease. After the first line was completed, a second line, PTX (60mg-80mg/m^2/infused on Day 1/week, three weeks and withdrawal for a week), was started two weeks later. PTX was repeated until progression of the disease. No severe adverse events (≧National Cancer Institute Common Toxicity Criteria ((NCICTC) grade 3) were observed. The median survival time (MST) overall including the first line and second line was 295 days. The hospitalization period was 60.0 days throughout the median of the total hospital stay and the rate was 25.6% in overall survival. There was no significant difference by histological type, metastasis, liver metastasis, or peritoneal dissemination. The median duration of TWiST as quality-adjusted survival analysis was 353 days in good performance status (PS) and 72 days in poor PS. S-1 followed by weekly PTX for various advanced inoperable gastric cancers appears to be a promising, appropriate, and well-tolerated anticancer chemotherapy regimen in an outpatient setting. 続きを見る
E-Resources:
本文リンク
タイトルが類似している資料

類似資料:

1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 

ITO, Kazushige, KASUYA, Kazuhiko, AOKI, Tatsuya, TAKAGI, Yu, KATAYANAGI, So, TSUCHIDA, Akihiko, KOYANAGI, Yasuhisa

Niigata University School of Medicine

Hasegawa, Toshiaki

新潟大学大学院自然科学研究科

Wakasugi, Minako, Narita, Ichiei, Iseki, Kunitoshi, Moriyama, Toshiki, Yamagata, Kunihiro, Tsuruya, Kazuhiko, Yoshida, …

Springer

Shimada, Kazuhiko, Watanabe, Takeshi, Sengoku, Masakazu, Abe, Takeo

The Institute of Electronics, Information and Communication Engineers

Watanabe, Kenichi, Hirokawa, Yoichi, Hirosawa, Hideo, Ohara, Kazuhiko, Kamimura, Akira, Yoshida, Hideharu, Furukawa, …

Niigata University School of Medicine

Shimada, Kazuhiko, Sengoku, Masakazu, Abe, Takeo

The Institute of Electronics, Information and Communication Engineers

Hori, Junichi, Sunaga, Kentarou, Watanabe, Satoru

電子情報通信学会

Ho, P. (Ping)

University Microfilms International